MiMedx Group Inc MDXG:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:31 PM EST
9.86quote price arrow up+0.33 (+3.46%)
Volume
322,928
52 week range
2.95 - 10.95

...

Loading . . .

KEY STATS

  • Open9.49
  • Day High10.16
  • Day Low9.49
  • Prev Close9.53
  • 52 Week High10.95
  • 52 Week High Date02/09/21
  • 52 Week Low2.95
  • 52 Week Low Date03/23/20
  • Market Cap1.095B
  • Shares Out111.05M
  • 10 Day Average Volume0.40M
  • Dividend-
  • Dividend Yield-
  • Beta1.64
  • 1 Year % Change37.9

RATIOS/PROFITABILITY

  • EPS (TTM)-0.67
  • P/E (TTM)-14.78
  • Fwd P/E (NTM)-197.20
  • EBITDA (MRQ)32.163M
  • ROE (MRQ)-277.41%
  • Revenue (MRQ)256.09M
  • Gross Margin (MRQ)83.90%
  • Net Margin (MRQ)-15.69%
  • Debt To Equity (MRQ)45.80%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest MiMedx Group Inc News

There is no recent news for this security.

Latest MDXG News From Our Partners

QUOTE FINDER

Profile

MORE
MiMedx Group, Inc. is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. Its biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn...
M. Kathleen Behrens Wilsey Ph.D.
Chairman
Timothy Wright
Chief Executive Officer
Peter Carlson
Chief Financial Officer
Rohit Kashyap Ph.D.
Executive Vice President
Robert Stein M.D. Ph.D.
Executive Vice President
William Hulse IV
General Counsel
Address
1775 W Oak Commons Ct
Marietta, GA
30062-2254
United States